Product description
Lidocaine Hydrochloride Topical Solution USP, 4%, 50mL
Batch numbers: 12636, 12639, 12868, 13057, 13061, 13260, 13510, 13626, 13969, 13971, 15338, 15344, 16265, 16375 and 16470
Supplied via Special Access Scheme (SAS)
See a list of details to help identify the product
Reason the product is recalled
The Lidocaine Hydrochloride topical solution can become stronger than intended.
The hazards to consumers
An increased dose of Lidocaine could lead to the development of local anaesthetic toxicity and this may result in serious adverse health effects.
What consumers should do
Consumers should immediately stop using the product and return it to the place of purchase or contact Medicianz Healthcare to arrange for credit note.
Any consumers concerned about their health should seek medical advice.
For further information, call Medicianz Healthcare on 1300 788 261.
Details to help identify the product
Supplier running the recall
Who sold the product
Hospitals in NSW, QLD, VIC and WA
Where the product was sold
Responsible regulators
Regulators are established or appointed by government. They enforce regulations and rules.
Quote PRA number 2022/19366 when contacting a regulator about this recall.
Recall and remedy questions
Contact the Therapeutic Goods Administration if you have:
- a question about the remedy being offered to you by the business that is responsible for managing this recall, or
- concerns about the way the business is managing this recall.